Checkpoint Therapeutics, Inc.
News
Head-To-Head Survey: Checkpoint Therapeutics (NASDAQ:CKPT) vs. Neoleukin Therapeutics (NASDAQ:NLTX)
Ticker Report Neoleukin Therapeutics (NASDAQ:NLTX - Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will...\n more…
Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire WALTHAM, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ( Checkpoint ) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that...\n more…
Checkpoint Therapeutics: A Binary Bet On FDA Approval And Cosibelimab's Market Success
SeekingAlpha Checkpoint Therapeutics: A Binary Bet On FDA Approval And Cosibelimab's Market Success...\n more…
Vanguard Group Inc. Buys 369,586 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)
Ticker Report Vanguard Group Inc. boosted its stake in shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT - Free Report) by 67.4% during the first quarter, according to the company in its most recent Form 13F...\n more…
Checkpoint Therapeutics files secondary offering of up to 5.9M shares
SeekingAlpha.com: All News Checkpoint Therapeutics (CKPT) files prospectus for resale of 5.9M common stock shares by certain stockholders.\n more…
